Parallax Volatility Advisers
TAK icon

Parallax Volatility Advisers’s Takeda Pharmaceutical TAK Stock Holding History

Parallax Volatility Advisers’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,300
Closed -$71K – 2326
2021
Q3 		$71K Buy
+4,300
New +$72.2K ﹤0.01% 1797
2019
Q2 		– Sell
-100,000
Closed -$2.04M – 3689
2019
Q1 		$2.04M Buy
+100,000
New +$2.01M ﹤0.01% 994

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Parallax Volatility Advisers's TAK Position: Q3 2019 in Review

Parallax Volatility Advisers sold out of Takeda Pharmaceutical (TAK) in Q3 2019, closing a stake of 400 shares — an estimated $7K sold.

Parallax Volatility Advisers first reported a position in TAK in Q1 2019 and held it in 2 quarters. The position peaked at $194K in Q1 2019. 317 funds tracked by Wall St. Rank hold TAK as of Q3 2019.

  • Parallax Volatility Advisers reported no remaining Takeda Pharmaceutical position as of Q3 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 400 Takeda Pharmaceutical shares in Q3 2019, an estimated $7K.
  • Parallax Volatility Advisers first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 2 quarters.
  • Parallax Volatility Advisers's Takeda Pharmaceutical position peaked at $194K in Q1 2019.
  • 317 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2019.

Based on Parallax Volatility Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.